Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Serum and Cellular Biomarkers Cluster for the Assessment of Degenerative Aortic Valve Stenosis Progression.

NCT04312139 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.

NCT NCT04312139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Serum and Cellular Biomarkers Cluster for the Assessment of Degenerative Aortic Valve Stenosis Progression.
Lead sponsor
National and Kapodistrian University of Athens
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2020
Completion date
September 30, 2025
Enrollment
280 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, aortic valve, calcification of, calcific aortic valve disease